Reduction of post-prandial hyperglycemia by mulberry tea in type-2 diabetes patients

Saudi Journal of Biological Sciences

Volumn 22, Issue 1, 2015, Pages 32-36

  Banu, Shaheena ^a   Jabir, Nasimudeen R ^b   Manjunath, Nanjappa C ^a   Khan, Mohd Shahnawaz ^c   Ashraf, Ghulam Md ^b   Kamal, Mohammad Amjad ^b   Tabrez, Shams ^b  

^a SRI JAYADEVA INSTITUTE OF CARDIOVASCULAR SCIENCES AND RESEARCH   (India)

^b KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Glucose level; Metabolic disorders; Mulberry tea; Post prandial hyperglycemia; Type 2 diabetes

Indexed keywords

MORUS (PLANT);

EID: 84919863640     PISSN: 1319562X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sjbs.2014.04.005     Document Type: Article

References (45)

1. Adisakwattana S., Chanathong B. Alpha-glucosidase inhibitory activity and lipid-lowering mechanisms of Moringa oleifera leaf extract. Eur. Rev. Med. Pharmacol. Sci. 2011, 15:803-808.
2. Adisakwattana S., Ruengsamran T., Kampa P., Sompong W. In vitro inhibitory effects of plant-based foods and their combinations on intestinal α-glucosidase and pancreatic α-amylase. BMC Complement. Altern. Med. 2012, 12.
3. Akilen R., Tsiami A., Devendra D., Robinson N. Cinnamon in glycaemic control: systematic review and meta analysis. Clin. Nutr. 2012, 31:609-615.
4. American Diabetes Association, 2010. Diagnosis and classification of diabetes mellitus. Diabetes Care 34, S62-S69.
5. American Diabetes Association, 2011. Standards of Medical Care in Diabetes-2012. Diabetes Care 35, S11-S63.
6. Banu S., Jabir N.R., Manjunath N.C., Firoz C.K., Kamal M.A., Tabrez S. Comparative study on non-HDL cholesterol levels and lipid profile in pre-diabetic and diabetic patients. CNS Neurol. Disord. Drug Targets 2013, 13:402-407.
7. Bell D.S.H., O'Keefe J.H., Jellinger P. Postprandial dysmetabolism: the missing link between diabetes and cardiovascular events?. Endocr. Pract. 2008, 14:112-124.
8. Blaak E.E., Antoine J.M., Benton D., Björck I., Bozzetto L., Brouns F., Diamant M., Dye L., Hulshof T., Holst J.J., Lamport D.J., Laville M., Lawton C.L., Meheust A., Nilson A., Normand S., Rivellese A.A., Theis S., Torekov S.S., Vinoy S. Impact of postprandial glycaemia on health and prevention of disease. Obes. Rev. 2012, 13:923-984.
9. Brand-Miller J.C., Holt S.H.A., Pawlak D.B., McMillan J. Glycemic index and obesity. Am. J. Clin. Nutr. 2002, 76:281S-285S.
10. Bulku E., Zinkovsky D., Patel P., Javia V., Lahoti T., Khodos I., Stohs S.J., Ray S.D. A novel dietary supplement containing multiple phytochemicals and vitamins elevates hepatorenal and cardiac antioxidant enzymes in the absence of significant serum chemistry and genomic changes. Oxid. Med. Cell. Longev. 2010, 3:129-144.
11. Cade W.T. Diabetes-related microvascular and macrovascular diseases in the physical therapy setting. Phys. Ther. 2008, 88:1322-1335.
12. Chan K.-C., Yang M.-Y., Lin M.-C., Lee Y.-J., Chang W.-C., Wang C.-J. Mulberry leaf extract inhibits the development of atherosclerosis in cholesterol-fed rabbits and in cultured aortic vascular smooth muscle cells. J. Agric. Food Chem. 2013.
13. Chiasson J.-L., Josse R.G., Gomis R., Hanefeld M., Karasik A., Laakso M. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 2002, 359:2072-2077.
14. Deepa M., Sureshkumar T., Satheeshkumar P.K., Priya S. Purified mulberry leaf lectin (MLL) induces apoptosis and cell cycle arrest in human breast cancer and colon cancer cells. Chem. Biol. Interact. 2012, 200:38-44.
15. Dembinska-Kiec A., Mykkänen O., Kiec-Wilk B., Mykkänen H. Antioxidant phytochemicals against type 2 diabetes. Br. J. Nutr. 2008, 99 E(Suppl 1). ES109-117.
16. Derosa G., Maffioli P. α-Glucosidase inhibitors and their use in clinical practice. Arch. Med. Sci. 2012, 8:899-906.
17. Devi V.K., Jain N., Valli K.S. Importance of novel drug delivery systems in herbal medicines. Pharmacog. Rev. 2010, 4:27-31.
18. Helzner E.P., Luchsinger J.A., Scarmeas N., Cosentino S., Brickman A.M., Glymour M.M., Stern Y. Contribution of vascular risk factors to the progression in Alzheimer disease. Arch. Neurol. 2009, 66:343-348.
19. Huang Y.-N., Zhao D.-D., Gao B., Zhong K., Zhu R.-X., Zhang Y., Xie W.-J., Jia L.-R., Gao H. Anti-hyperglycemic effect of chebulagic acid from the fruits of Terminalia chebula retz. Int. J. Mol. Sci. 2012, 13:6320-6333.
20. Jabir N.R., Kamal M.A., Abuzenadah A.M., Gan S.H., Alama M.N., Baeesa S.S., Tabrez S. Alzheimer's and type 2 diabetes management via common enzyme targeting. CNS Neurol. Disord. Drug Targets 2014, 13:299-304.
21. Jaruchotikamol A., Pannangpetch P. Cytoprotective activity of mulberry leaf extract against oxidative stress-induced cellular injury in rats. Pak. J. Pharm. Sci. 2013, 26:163-168.
22. Kagansky N., Levy S., Rimon E., Cojocaru L., Fridman A., Ozer Z., Knobler H. Hypoglycemia as a predictor of mortality in hospitalized elderly patients. Arch. Intern. Med. 2003, 163:1825-1829.
23. Kamal M.A., Priyamvada S., Anbazhagan A.N., Jabir N.R., Tabrez S., Greig N.H. Linking Alzheimer's disease and type 2 diabetes mellitus via aberrant insulin signaling and inflammation. CNS Neurol. Disord. Drug Targets 2014, 13:338-346.
24. Kamboj J., Sharma S., Kumar S. In vivo anti-diabetic and anti-oxidant potential of Psoralea corylifolia seeds in streptozotocin induced type-2 diabetic rats. J. Health Sci. 2011, 57:225-235.
25. Kim G.-N., Kwon Y.-I., Jang H.-D. Mulberry leaf extract reduces postprandial hyperglycemia with few side effects by inhibiting α-glucosidase in normal rats. J. Med. Food 2011, 14:712-717.
26. Kumar S., Sharma S., Vasudeva N., Ranga V. In vivo anti-hyperglycemic and antioxidant potentials of ethanolic extract from Tecomella undulata. Diabetol. Metab. Syndr. 2012, 4.
27. Kwon H.J., Chung J.Y., Kim J.Y., Kwon O. Comparison of 1-deoxynojirimycin and aqueous mulberry leaf extract with emphasis on postprandial hypoglycemic effects: in vivo and in vitro studies. J. Agric. Food Chem. 2011, 59:3014-3019.
28. Leiherer A., Mündlein A., Drexel H. Phytochemicals and their impact on adipose tissue inflammation and diabetes. Vascul. Pharmacol. 2013, 58:3-20.
29. Naowaboot J., Pannangpetch P., Kukongviriyapan V., Prawan A., Kukongviriyapan U., Itharat A. Mulberry leaf extract stimulates glucose uptake and GLUT4 translocation in rat adipocytes. Am. J. Chin. Med. 2012, 40:163-175.
30. Oku T., Yamada M., Nakamura M., Sadamori N., Nakamura S. Inhibitory effects of extractives from leaves of Morus alba on human and rat small intestinal disaccharidase activity. Br. J. Nutr. 2006, 95:933-938.
31. Ono Y., Kameda H., Cho K.Y. Mitiglinide/voglibose fixed-dose combination improves postprandial glycemic excursions in Japanese patients with type 2 diabetes mellitus. Expert Opin. Pharmacother. 2013, 14:361-370.
32. Painter N.A., Morello C.M., Singh R.F., McBane S.E. An evidence-based and practical approach to using Bydureon™ in patients with type 2 diabetes. JABFM 2013, 26:203-210.
33. Park J.M., Bong H.Y., Jeong H.I., Kim Y.K., Kim J.Y., Kwon O. Postprandial hypoglycemic effect of mulberry leaf in Goto-Kakizaki rats and counterpart control Wistar rats. Nutr. Res. Pract. 2009, 3:272-278.
34. Park S., Kim J., Kim Y. Mulberry leaf extract inhibits cancer cell stemness in neuroblastoma. Nutr. Cancer 2012, 64:889-898.
35. Prince P.S., Menon V.P., Pari L. Hypoglycaemic activity of Syzigium cumini seeds: effect on lipid peroxidation in alloxan diabetic rats. J. Ethnopharmacol. 1998, 61:1-7.
36. Rodbard H.W., Jellinger P.S., Davidson J.A., Einhorn D., Garber A.J., Grunberger G., Handelsman Y., Horton E.S., Lebovitz H., Levy P., Moghissi E.S., Schwartz S.S. Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control. Endocr. Pract. 2009, 15:540-559.
37. Sharma S.B., Gupta S., Ac R., Singh U.R., Rajpoot R., Shukla S.K. Antidiabetogenic action of Morus rubra L. leaf extract in streptozotocin-induced diabetic rats. J. Pharm. Pharmacol. 2010, 62:247-255.
38. Shiraiwa T., Kaneto H., Miyatsuka T., Kato K., Yamamoto K., Kawashima A., Kanda T., Suzuki M., Imano E., Matsuhisa M., Hori M., Yamasaki Y. Postprandial hyperglycemia is a better predictor of the progression of diabetic retinopathy than HbA1c in Japanese type 2 diabetic patients. Diabetes Care 2005, 28:2806-2807.
39. Solís I., Hurtado N., Demangel D., Cortés C., Soto N. Glycemic control in diabetic patients hospitalized in a non-critical care hospital setting. Rev. Med. Chil. 2012, 140:66-72.
40. Tabrez S., Priyadarshini M., Urooj M., Shakil S., Ashraf G.M., Khan M.S., Kamal M.A., Alam Q., Jabir N.R., Abuzenadah A.M., Chaudhary A.G.A., Damanhouri G.A. Cancer chemoprevention by polyphenols and their potential application as nanomedicine. J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev. 2013, 31:67-98.
41. Tosh S.M. Review of human studies investigating the post-prandial blood-glucose lowering ability of oat and barley food products. Eur. J. Clin. Nutr. 2013, 67:310-317.
42. Turchin A., Matheny M.E., Shubina M., Scanlon J.V., Greenwood B., Pendergrass M.L. Hypoglycemia and clinical outcomes in patients with diabetes hospitalized in the general ward. Diabetes Care 2009, 32:1153-1157.
43. Ye F., Shen Z., Xie M. Alpha-glucosidase inhibition from a Chinese medical herb (Ramulus mori) in normal and diabetic rats and mice. Phytomedicine 2002, 9:161-166.
44. Zaidi S.K., Hoda M.N., Tabrez S., Ansari S.A., Jafri M.A., Shahnawaz Khan M., Hasan S., Alqahtani M.H., Mohammed Abuzenadah A., Banu N. Protective effect of Solanum nigrum leaves extract on immobilization stress induced changes in rat's brain. Evid. Based Complement. Alternat. Med. 2014, 2014. Article ID: 912450, http://dx.doi.org/10.1155/2014/912450.
45. Zimmet P.Z. The growing pandemic of type 2 diabetes: a crucial need for prevention and improved detection. Medicographia 2011, 33:15-21.